Back to Search
JOHN TESSER, MD
MD
Rheumatology Physician
NPI: 1427049220IndividualAccepts Medicare
Specialties, Licenses & Credentials
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
11285(AZ)
CMS Specialties
PrimaryRHEUMATOLOGY
Education
UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY
Class of 1977
Research & Publications (14)
Concomitant medication use in a large, international, multicenter, placebo controlled trial of anakinra, a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis.
PMID 15088288·J Rheumatol·2004
3-trial
A 4-week randomized study of acetaminophen extended-release vs rofecoxib in knee osteoarthritis.
PMID 18640856·Osteoarthritis Cartilage·2009
4-observational
Evaluating the adequacy of disease control in patients with rheumatoid arthritis: a RAND appropriateness panel.
PMID 18178593·Rheumatology (Oxford)·2008
4-observational
The evolution of biomarkers in rheumatoid arthritis: from clinical research to clinical care.
PMID 18847311·Expert Opin Biol Ther·2008
6-review
Effects of consuming foods containing oat beta-glucan on blood pressure, carbohydrate metabolism and biomarkers of oxidative stress in men and women with elevated blood pressure.
PMID 17151592·Eur J Clin Nutr·2007
4-observational
Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis.
PMID 16465653·J Rheumatol·2006
4-observational
Safety of extended treatment with anakinra in patients with rheumatoid arthritis.
PMID 16396977·Ann Rheum Dis·2006
4-observational
Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists.
PMID 15188373·Arthritis Rheum·2004
5-case
The safety of anakinra in high-risk patients with active rheumatoid arthritis: six-month observations of patients with comorbid conditions.
PMID 15188350·Arthritis Rheum·2004
3-trial
Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial.
PMID 12687534·Arthritis Rheum·2003
3-trial
Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes.
PMID 12115173·Arthritis Rheum·2002
3-trial
CD4 coating, but not CD4 depletion, is a predictor of efficacy with primatized monoclonal anti-CD4 treatment of active rheumatoid arthritis.
PMID 11838838·J Rheumatol·2002
3-trial
Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis.
PMID 11438043·Arthritis Res·2001
3-trial
A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis.
PMID 11096165·N Engl J Med·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 5681 W BEVERLY LN STE 100
GLENDALE, AZ 85306 - Phone
- (480) 443-8400
Quick Facts
- NPI
- 1427049220
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 49
- Publications
- 14
Are you this provider?
Claim Your Profile